SCHEMBL7947069

SCHEMBL7947069

CC(C)n1c(=O)c(-c2cccc(C#N)c2)nc2c(N)ccnc21

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MTOR P42345 2/20 0.48
PIK3CD O00329 1/20 0.48
ABL1 P00519 1/20 0.48
EGFR P00533 1/20 0.48
HCK P08631 1/20 0.48
SRC P12931 1/20 0.48
KDR P35968 1/20 0.48
PIK3CA P42336 1/20 0.48
PIK3CG P48736 1/20 0.48
EPHB4 P54760 1/20 0.48
PRKDC P78527 1/20 0.48
PI4KB Q9UBF8 1/20 0.48
KDM5B Q9UGL1 1/20 0.47
CYP1A2 P05177 9/20 0.44
CASP1 P29466 7/20 0.44
CASP7 P55210 7/20 0.44
HSD17B10 Q99714 7/20 0.44
ALDH1A1 P00352 7/20 0.43
USP2 O75604 6/20 0.43
CYP3A4 P08684 6/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7938047 0.86 CYP1A2 (0.56) MTORPIK3CDABL1EGFRHCK
SCHEMBL7946228 0.84 MTOR (0.48) MTORKDM5BCYP1A2HSD17B10ALDH1A1
SCHEMBL7946753 0.82 ALDH1A1 (0.52) CYP1A2CASP1CASP7HSD17B10ALDH1A1
SCHEMBL3223334 0.80 CYP1A2 (0.55) MTORPIK3CDABL1EGFRHCK
SCHEMBL7945959 0.80 PDE4B (0.51) CYP1A2CASP1CASP7HSD17B10ALDH1A1
SCHEMBL7944623 0.79 ALDH1A1 (0.66) CYP1A2CASP1CASP7HSD17B10ALDH1A1
SCHEMBL7944641 0.79 ALDH1A1 (0.45) CYP1A2CASP1CASP7HSD17B10ALDH1A1
SCHEMBL7944111 0.79 CYP1A2 (0.51) MTORPIK3CDABL1EGFRHCK
SCHEMBL7949559 0.78 ALDH1A1 (0.49) CYP1A2CASP1CASP7HSD17B10ALDH1A1
SCHEMBL7938295 0.78 ALDH1A1 (0.48) CYP1A2CASP1CASP7HSD17B10ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010008775-A1 AMINOPYRIDOPYRAZINONE DERIVATIVES FOR TREATING NEURODEGENERATIVE DISEASES LIGAND PHARMACEUTICALS INC. (US) 2010-01-21 WO disclosed